Dilsher Dhoot, MD, provides an overview of biosimilars in retinal diseases and discusses how he identifies patients suitable for biosimilar therapy.
Harnessing the Potential of Biosimilars in Retinal Disease Management
Dilsher Dhoot, MD, presents two cases involving DME and CRVO, that show remarkable anatomical improvement with a biosimilar comparable to those achieved with reference biologics.
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
STAAR and Broadwood conflict over proposed Alcon merger continues
2
Sharper vision starts here
3
Ocular surface: Targeted therapies for a multifactorial problem
4
Study finds retinal progenitor cell injections improve outcomes in rat model of diabetic retinopathy
5
.png "Optometry Times"){kind=logo}
